Minor depressive disorder and subsyndromal depressive symptoms: Functional impairment and response to treatment

Journal of Affective Disorders

Volumn 48, Issue 2-3, 1998, Pages 227-232

  Rapaport, Mark Hyman ^a,b   Judd, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Antidepressants; Depressive symptoms; Major depression pharmacology; Minor depression

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COST OF ILLNESS; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FLUVOXAMINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0031781243     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00196-1     Document Type: Article

References (17)

1. Broadhead W.E., Blazer D.G., George L.K., Tse C.K. Depression, disability days, and days lost from work in a prospective epidemiologic survey. J. Am. Med. Assoc. 264(19):1990;2524-2528.
2. Guy, W., 1976a. Global Assessment Scale. ECDEU Assessment Manual. U.S. Department of Health and Human Services, Rockville MD, pp. 583-585.
3. Guy, W., 1976b. Clinical Global Impressions (028-CGI). ECDEU Assessment Manual. U.S. Department of Health and Human Services, Rockville MD, pp. 217-222.
4. Hamilton B.A., Jones P.G., Hoda A.N., Keane P.M., Majid I., Zaidi S.I.A. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice. Pharmatherapeutica. 5:1989;292-297.
5. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
6. Hays R.D., Sherbourne C.D., Mazel R.M. The Rand 36-Item Health Survey 1.0. Health Econ. 2:1993;217-227.
7. Johnson J., Weissman M., Klerman G. Service utilization and social morbidity associated with depressive symptoms in the community. J. Am. Med. Assoc. 267(11):1992;1478-1483.
8. Judd L.L., Rapaport M.H., Paulus M.P., Brown J.L. Subsyndromal symptomatic depression: a mood disorder. J. Clin. Psychiatry. 55:1994;18-28.
9. Judd L.L., Paulus M.P., Wells K.B., Rapaport M.H. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am. J. Psychiatry. 153:1996;1411-1417.
10. Miranda J., Munoz R. Intervention for minor depression in primary care patients. Psychosom. Med. 56:1994;136-142.
11. Paykel E.S., Freeling P., Hollyman J.A. Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry. 21:1988;15-18.
12. Paykel E.S., Hollyman J.A., Freeling P., Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J. Affect. Disord. 14:1988;83-95.
13. Robins, L.N., Helzer, J.E., Croughan, J., Williams, J.B.W., Spitzer, R.L., 1981. NIMH Diagnostic Interview Schedule: Version III. National Institute of Mental Health, Rockville, MD.
14. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res. 18:1985;65-87.
15. Skodol A.E., Schwartz S., Dohrenwend B.P., Levav I., Shrout P.E. Minor depression in a cohort of young adults in Israel. Arch. Gen. Psychiatry. 51:1994;542-551.
16. Spitzer, R., Williams, J., Gibbon, M., First, M., 1988. Instruction manual for the structured clinical interview for DSM III-R (SCID). Columbia Press, New York.
17. Stewart J.W., Quitkin F.M., Liebowitz M.R., McGrath P.J., Harrison W.M., Klein D.F. Efficacy of desipramine in depressed outpatients. Arch. Gen. Psychiatry. 40:1983;202-207.